Letters in Drug Design and Discovery
Published by KeAi Communications Co.
ISSN : 1570-1808 eISSN : 1875-628X
Abbreviation : Lett. Drug Des. Discov.
Aims & Scope
Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships.
The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts.
The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 1.6 |
| 2024 | 1.20 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.310 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 40 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 16320 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 497 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.